Stories

Discover all of the trending stories of Ipsen Group.

Explore more by category

Filter

Period

Filter by

recent search

Showing: 15 of 202 stories

From culture to clinic: Alison Mason on making science work at scale 
 • 2 mins read

 – 2 mins read

From culture to clinic: Alison Mason on making science work at scale 

The science behind cell culture and fermentation rarely makes headlines. But without it, no treatment would reach a patient. Alison Mason knows this better than most.


A Life in Science: Shaping early development with patient focus
 • 2 mins read

 – 2 mins read

A Life in Science: Shaping early development with patient focus

New in our A Life in Science series, we hear from Mary Jane Hinrichs, Senior Vice President and Head of Early Development, about her path from discovering a passion for pharmacology to leading drug candidates through first-in-human trials. She shares how balancing strategy, science, and a constant focus on patients motivates her to shape the future of medicines.


Ipsen 2026 Annual General Meeting
 • 0 mins read

 – 0 mins read

Ipsen 2026 Annual General Meeting

A replay with complete presentation and Q&A session will be made available soon after the Annual General Meeting.


A Life in Science: Curiosity and collaboration in cancer research
 • 1 mins read

 – 1 mins read

A Life in Science: Curiosity and collaboration in cancer research

New in our A Life in Science series, we hear from Elodie Lewkowicz, Asset Lead, about how curiosity and collaboration drive her mission to tackle the complexity of cancer. She reflects on mentoring, developing the next generation of scientists, and keeping patients at the heart of every data point to stay motivated through challenges.


Moving NET Science Forward Together at ENETS 2026
 • 2 mins read

 – 2 mins read

Moving NET Science Forward Together at ENETS 2026

The European Neuroendocrine Tumor Society (ENETS) 4 – 6 March 2026 conference in Kraków is one of the most important moments of the year for the global NET community. Clinicians, researchers, nurses, advocates and partners come together with a shared purpose to expand understanding of neuroendocrine tumors (NETs) and improve care for people living with them.